Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 45.85
+6.80 (17.41%)
Mar 27, 2025, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 75.11 billion as of March 27, 2025. Its market cap has increased by 11.01% in one year.
Market Cap
75.11B
Enterprise Value
69.44B
Revenue
8.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
45.85
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 75.11B, an increase of 305.15%. That is a compound annual growth rate of 24.40%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 211.67B |
| Hansoh Pharmaceutical Group Company | 120.47B |
| WuXi Biologics | 107.97B |
| JD Health International | 104.31B |
| Alibaba Health Information Technology | 81.53B |
| Sino Biopharmaceutical | 63.38B |
| Akeso | 59.55B |
| Sichuan Kelun-Biotech Biopharmaceutical | 59.23B |